Journal of Ophthalmic and Vision Research

ISSN: 2008-322X

The latest research in clinical ophthalmology and vision science

Efficacy, Safety and Steroid-sparing Effect of Topical Cyclosporine A 0.05% for Vernal Keratoconjunctivitis in Indian Children

Published date:Oct 24 2019

Journal Title: Journal of Ophthalmic and Vision Research

Issue title: October–December 2019, Volume 14, Issue 4

Pages:412 – 418

DOI: 10.18502/jovr.v14i4.5439

Authors:

Arkendu ChatterjeeNRS Medical College & Hospital, Kolkata, India

Sabyasachi Bandyopadhyaysabyasachi.bandyopadhyay@yahoo.comR.G.Kar Medical College & Hospital, Kolkata, India

Samir Kumar BandyopadhyayNRS Medical College & Hospital, Kolkata, India

Abstract:

Purpose: To evaluate the efficacy, safety, and steroid-sparing effect of topical cyclosporine A (Cs A) 0.05% in patients with moderate to severe steroid dependent vernal keratoconjunctivitis (VKC).

Methods: A prospective, comparative, placebo controlled study was carried out on 68 VKC patients, with 34 patients treated with topical Cs A 0.05% and the remaining 34 with topical carboxymethyl cellulose 0.5% (placebo). Both groups also received topical loteprednol etabonate 0.5%. Symptom (itching, photophobia, tearing, and discharge) score, sign (tarsal and limbal papillae, corneal involvement, and conjunctival hyperemia) score, and drug score (steroid drop usage/day/eye) were recorded at baseline and each followup visit. The intraocular pressure (IOP) measurement and evaluation of any ocular side effects were carried out.

Results: Significant reduction in symptom score and sign score was seen in both groups. Cs A group significantly showed more reduction in symptom (P < 0.0001 in all follow-up visits) and sign (P < 0.0001 in all follow-up visits) scores compared to the placebo group. At day 7, mean steroid usage reduced from 4 to 3.44 ± 0.5 and 3.79 ± 0.4 in Cs A and placebo groups, respectively (P < 0.0001). Steroid drops completely stopped in 21 patients at day 60 in the Cs A group compared to none in the placebo group. No significant rise in IOP or any side effects were noted in either group.

Conclusion: Topical Cs A 0.05% is effective and safe in patients with moderate to severe VKC with good steroid-sparing effect.

Keywords: Allergic Conjunctivitis, Intraocular Pressure, Topical Cyclosporine A, Topical Loteprednol Etabonate, Vernal Keratoconjunctivitis

References:

1. Leonardi A. Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Retin Eye Res 2002;21:319–339.

2. Leonardi A, Secchi AG. Vernal keratoconjunctivitis. Int Ophthalmol Clin 2003;43:41–58.

3. Vichyanond P, Pacharn P, Pleyer U, Leonardi A. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes. Pediatr Allergy Immunol 2014;25:314–322.

4. Ozlem EY, Nihal DU. Efficacy and safety of topical Cyclosporine A 0.05% in vernal keratoconjunctivitis. Singapore Med J 2016;57:507–510.

5. Leonardi A. Management of Vernal keratoconjunctivitis. Ophthalmol Ther 2013;2:73–88.

6. Allansmith MR, Ross RN. Ocular allergy and mast cell stabilizers. Surv Ophthalmol 1986;30:229–244.

7. Gokhale NS. Systematic approach to managing vernal keratoconjunctivitis in clinical practice: severity grading system and a treatment algorithm. Indian J Ophthalmol 2016;64:145–148.

8. McGhee CN, Dean S, Danesh-Meyer H. Locally administered ocular corticosteroids: benefits and risks. Drug Saf 2002;25:33–55.

9. Oner V, Turkeu FM, Tas M, Iscan Y. Topical loteprednol etabonate 0.5% for treatment of vernal keratoconjunctivitis: efficacy and safety. Jpn J Ophthalmol 2012;56:312– 318.

10. Eliaçık M, Erdoğan F, Bayramlar H, Karaman S, Gülkılık G. Comparison of efficacy and safety of Loteprednol etabonate 0.5% versus fluorometholone acetate 0.1% for the treatment of vernal keratoconjunctivitis in pediatric subjects. Nobel Med 2014;11:76–82.

11. Wu LQ, Chen X, Lu H, Cheng JW, Wei RL. Loteprednol etabonate in the treatment of allergic conjunctivitis: a meta-analysis. Curr Med Res Opin 2015;31:1509–1518.

12. Fukushima A, Yamaguchi T, Ishida W, Fukata K, Liu FT, Ueno H. Cyclosporin A inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions. Clin Exp Ophthalmol 2006;34:347–353.

13. Kari O, Saari KM. Updates in the treatment of ocular allergies. J Asthma Allergy 2010;3:149–158. 14. Daniell M, Constantinou M, Vu HT, Taylor HR. Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis. Br J Ophthalmol 2006;90:461– 464.

15. Tatlipinar S, Akpek EK. Topical cyclosporin in the treatment of ocular surface disorders. Br J Ophthalmol 2005;89:1363–1367.

16. Baiza-Duran LM, González-Villegas AC, Contreras-Rubio Y, Juarez-Echenique JC, Vizzuett-Lopez IV, Suarez- Sanchez R, et al. Safety and efficacy of topical 0.1% and 0.05% cyclosporine A in an aqueous solution in steroiddependent vernal keratoconjunctivitis in a population of Mexican children. J Clin Exp Ophthalmol 2010;1:115. doi: 10.4172/2155-9570.1000115

17. Hingorani M, Moodaley L, Calder VL, Buckley RJ, Lightman S. A randomized placebo-controlled trial of topical cyclosporine A in steroid-dependent atopic keratoconjunctivitis. Ophthalmology 1998;105:1715–1720.

18. Pucci N, Novembre E, Cianferoni A, Lombardi E, Bernardini R, Caputo R, et al. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Ann Allergy Asthma Immunol 2002;89:298–303.

19. Spadavecchia L, Fanelli P, Tesse R, Brunetti L, Cardinale F, Bellizzi M, et al. Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood. Pediatr Allergy Immunol 2006;17:527–532.

20. Keklikci U, Soker SI, Sakalar YB, Unlu K, Ozekinci S, Tunik S. Efficacy of topical cyclosporine A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children. Jpn J Ophthalmol 2008;52:357–362.

21. Akpek EK, Dart JK, Watson S, Christen W, Dursun D, Yoo S, et al. A randomized trial of topical cyclosporine 0.05% in topical steroid-resistant atopic keratoconjunctivitis. Ophthalmology 2004;111:476–482.

22. De Smedt S, Nkurikiye J, Fonteyne Y, Tuft S, De Bacquer D, Gilbert C, et al. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, central Africa: a prospective, randomised, double-masked, controlled clinical trial. Br J Ophthalmol 2012;96:323–328.

23. Wu MM, Yau GS, Lee JW, Wong AL, Tam VT, Yuen CY. Retrospective review on the use of topical cyclosporin a 0.05% for pediatric allergic conjunctivitis in Hong Kong Chinese. Scient World J 2014;2014:396987. doi: 10.1155/2014/396987

24. Keklikci U, Dursun B, Cingu AK. Topical cyclosporin A 0.05 % eye drops in the treatment of vernal keratoconjunctivitis. Randomized placebo-controlled trial. Adv Clin Exp Med 2014;23:455–461.

Recommendations
EDITORIAL
Dimitrios Papandreou, ARAB JOURNAL OF NUTRITION AND EXERCISE (AJNE), 2022
CONFERENCE SHORT REPORT – DUBAI HOSTS 7TH INTERNATIONAL NUTRITION CONGRESS
Nutrition Conference Report Dubai, ARAB JOURNAL OF NUTRITION AND EXERCISE (AJNE), 2022
POSTPARTUM MATERNAL HEALTH AT A TIME OF RAPID SOCIETAL CHANGE IN ABU DHABI, UNITED ARAB EMIRATES
Hazel Gardner et al., ARAB JOURNAL OF NUTRITION AND EXERCISE (AJNE), 2018
FOOD SAFETY KNOWLEDGE AMONG CHICKEN SHAWERMA FOOD HANDLERS IN AMMAN- JORDAN
A. M. et al., ARAB JOURNAL OF NUTRITION AND EXERCISE (AJNE), 2018
INTUITIVE EATING AND WEIGHT RESTRICTIVE PRACTICES AMONG DIETITIANS IN KUWAIT
Dalal Alkazemi et al., ARAB JOURNAL OF NUTRITION AND EXERCISE (AJNE), 2019
THE EFFECT OF TRAINING MOTHERS ON MODIFYING THE MEAL BOXES OF THEIR PRESCHOOLERS WITH VEGETABLES AND FRUITS IN THE SUB-DISTRICT OF TANGERANG, TANGERANG CITY, BANTEN PROVINCE
A. Faridi et al., ARAB JOURNAL OF NUTRITION AND EXERCISE (AJNE), 2019
PREVALENCE OF COMPLICATIONS IN TYPE 2 DIABETICS IN DUBAI, UAE: A CROSS-SECTIONAL STUDY
H. A. Sabbah et al., ARAB JOURNAL OF NUTRITION AND EXERCISE (AJNE), 2019
PREVALENCE AND CORRELATES OF DISORDERED EATING ATTITUDES AMONG JORDANIAN ADOLESCENTS
Tamer Ghraiybah, ARAB JOURNAL OF NUTRITION AND EXERCISE (AJNE), 2018
AN ASSESSMENT OF THE NUTRITIONAL STATUS OF STUDENTS IN GOVERNMENTAL PRIMARY SCHOOLS IN U.A.Q.
Shaza Shaaban Zackaria et al., ARAB JOURNAL OF NUTRITION AND EXERCISE (AJNE), 2019
EFFECT OF SOY MILK AND MUNG BEAN PORRIDGE ON SERUM TRIGLYCERIDES AMONG POSTMEN-OPAUSAL WOMEN
Fendie K. Syailawan et al., ARAB JOURNAL OF NUTRITION AND EXERCISE (AJNE), 2019
Powered by
Download
HTML
Cite
Share
statistics

1081 Abstract Views

617 PDF Downloads